Logo News Medizin 2000  
        >    Zurück

 | Home | Suche | Nutzung | Impressum| Kontakt |

Themen Websites
Info-Netzwerk MEDIZIN 2000

 

 

 

 

Der Allergie vorbeugen: haben Kinder im ersten Lebensjahr Kontakt zu 2 oder mehr Hunden oder Katzen, so vermindert sich das spätere Allergierisiko ganz erheblich.

 


Exposure to Dogs and Cats in the First Year of Life and Risk of Allergic Sensitization at 6 to 7 Years of Age  
 
 
 Dennis R. Ownby, MD; Christine Cole Johnson, PhD; Edward L. Peterson, PhD

 

Context  Childhood asthma is strongly associated with allergic sensitization. Studies have suggested that animal exposure during infancy reduces subsequent allergic sensitization.

Objective  To evaluate the relationship between dog and cat exposure in the first year of life and allergic sensitization at 6 to 7 years of age.

Design, Setting, and Subjects  Prospective birth cohort study of healthy, full-term infants enrolled in a health maintenance organization in suburban Detroit, Mich, who were born between April 15, 1987, and August 31, 1989, and followed up yearly to a mean age of 6.7 years. Of 835 children initially in the study at birth, 474 (57%) completed follow-up evaluations at age 6 to 7 years.

Main Outcome Measures  Atopy, defined as any skin prick test positivity to 6 common aeroallergens (dust mites [Dermatophagoides farinae, D pteronyssinus], dog, cat, short ragweed [Ambrosia artemisiifolia], and blue grass [Poa pratensis]); seroatopy, defined as any positive allergen-specific IgE test result for the same 6 allergens or for Alternaria species.

Results  The prevalence of any skin prick test positivity (atopy) at age 6 to 7 years was 33.6% with no dog or cat exposure in the first year of life, 34.3% with exposure to 1 dog or cat, and 15.4% with exposure to 2 or more dogs or cats (P = .005). The prevalence of any positive allergen-specific IgE test result (seroatopy) was 38.5% with no dog or cat exposure, 41.2% with exposure to 1 dog or cat, and 17.9% with exposure to 2 or more dogs or cats (P = .003). After adjustment for cord serum IgE concentration, sex, older siblings, parental smoking, parental asthma, bedroom dust mite allergen levels at 2 years, and current dog and cat ownership, exposure to 2 or more dogs or cats in the first year of life was associated with a significantly lower risk of atopy (adjusted odds ratio, 0.23; 95% confidence interval, 0.09-0.60) and seroatopy (adjusted odds ratio, 0.33; 95% confidence interval, 0.13-0.83).

Conclusion  Exposure to 2 or more dogs or cats in the first year of life may reduce subsequent risk of allergic sensitization to multiple allergens during childhood.

JAMA. 2002;288:963-972

View Full Text      
 
Author/Article Information
 
 
Author Affiliations: Section of Allergy and Immunology, Department of Pediatrics, Medical College of Georgia, Augusta (Dr Ownby); Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Mich (Drs Johnson and Peterson); National Institute of Environmental Health Sciences Center in Molecular and Cellular Toxicology with Human Applications, Wayne State University, Detroit (Drs Johnson and Peterson).
 
Corresponding Author and Reprints: Dennis R. Ownby, MD, Section of Allergy and Immunology, Department of Pediatrics, BG-1019, Medical College of Georgia, Augusta, GA 30912-3790 (e-mail: downby@mail.mcg.edu).

Author Contributions: Study concept and design: Ownby, Johnson.

Acquisition of data: Ownby, Johnson.

Analysis and interpretation of data: Ownby, Johnson, Peterson.

Drafting of the manuscript: Ownby, Johnson, Peterson.

Critical revision of the manuscript for important intellectual content: Ownby, Johnson, Peterson.

Statistical expertise: Peterson.

Obtained funding: Ownby, Johnson.

Administrative, technical, or material support: Ownby, Johnson.

Study supervision: Ownby, Johnson.

Funding/Support: This work was supported by grant AI 24156 from the National Institute of Allergic and Infectious Diseases, by the Fund for Henry Ford Hospital, and by grant PO3ES06639 from the National Institute of Environmental Health Sciences.

Financial Disclosure: Dr Ownby has received honoraria from AstraZeneca, Genentech, GlaxoSmithKline, Schering, Merck, and Aventis.


 

 

zur Originalquelle

 

 

 

 

 

...................

Seelische Belastungen bei Krebs
Was tun, um mit dieser Krisensituation fertig zu werden?

 

Krebspatienten und ihre Angehörigen leiden unter  kaum erträglichen seelischen Belastungen. Bisher ist wenig darüber bekannt, wie sie mit diesem Problem im Alltag umgehen. Um mehr über die geistig-seelischen Aspekte der Krankheitsbewältigung zu erfahren, wird nun an der Pädagogischen Hochschule Freiburg eine Studie durchgeführt, die sich mit der Frage beschäftigt, wie die betroffenen Menschen ihrer Krebserkrankung umgehen und welche eigenen Möglichkeiten sie hierzu nutzen konnten. Als Grundlage für diese wichtige Studie dient ein online-Fragebogen.  KrebspatientInnen werden von der Autorin Anna-Katharina Burkhardt dazu ermutigt, diesen anonymisierten Fragebogen hier auszufüllen.

 

     
 


  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
   
 

  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
  SIT, spezifische Immuntherapie, Navigation
     

 

 

 

 

 

zum Seitenanfang

 


RSS Newsfeed auf Medizin 2000

Twitter auf Medizin 2000

Werbung auf Medizin 2000

 

Newsletter Immun Plus


Thymus Therapie bei Krebs

Sanorell Workshops Heilpraktiker und Ärzte

Biologischer Bypass Schwarzwald Medical Resort

 


 

 



Wichtige Themen-Websites im Info-Netzwerk Medizin 2000 
(13.12.2009)